IntegraGen announced unaudited revenue results for the full year 2022. The 2022 unaudited revenue amount to EUR 12,592,000 in 2022, representing an increase of 16% compared to 2021. This growth in all activities reflects the firmness of the company's positioning, both in terms of its main sequencing activities for R&D customers and its expertise in operating platforms on behalf of third parties.